AvanSight


Contract research organization (CRO) founded in 2020 that provides clinical trial consulting and technology solutions to biopharmaceutical companies and regulatory bodies. Core activities include biostatistics, statistical programming, clinical data management, regulatory submission support, pharmacovigilance, and a cloud-based clinical trial decision-support platform using automation and advanced analytics.

Industries

biotechnology
clinical-trials
consulting

Nr. of Employees

small (1-50)

AvanSight

Tustin, California, United States, North America


Products

Clinical trial decision-support platform

Platform providing analytics, automation, and decision support across the clinical trial lifecycle to aid trial design and evaluation.


Services

Statistical planning, analysis, and responses to regulatory review queries for clinical studies.

Clinical statistical programming and reporting to produce analysis datasets and submission-ready outputs.

Data capture, management, and database lock support aligned with regulatory guidance.

Preparation of regulatory documents and submissions to support approval processes.

Review and remediation of submission datasets and documents to reduce risk of regulatory delays.

End-to-end pharmacovigilance services and compliance review for safety monitoring.

View All Services

Expertise Areas

  • Clinical trial management
  • Biostatistics
  • Statistical programming
  • Clinical data management
  • Show More (5)

Key Technologies

  • Machine learning / AI for clinical analytics
  • Real-world data analytics
  • Cloud-based decision-support platforms
  • Statistical programming
  • Show More (2)

News & Updates

Company incorporated in November 2020.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.